Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab.
about
Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Serum anti-endothelial cell an ...... with intravitreal bevacizumab.
@en
Serum anti-endothelial cell an ...... with intravitreal bevacizumab.
@nl
type
label
Serum anti-endothelial cell an ...... with intravitreal bevacizumab.
@en
Serum anti-endothelial cell an ...... with intravitreal bevacizumab.
@nl
prefLabel
Serum anti-endothelial cell an ...... with intravitreal bevacizumab.
@en
Serum anti-endothelial cell an ...... with intravitreal bevacizumab.
@nl
P2093
P2860
P356
P1433
P1476
Serum anti-endothelial cell an ...... with intravitreal bevacizumab.
@en
P2093
Agnieszka Kubicka-Trząska
Bożena Romanowska-Dixon
Joanna Wilańska
P2860
P304
P356
10.1111/AOS.13033
P50
P577
2016-06-22T00:00:00Z